Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

35.00p
   
  • Change Today:
      0.100p
  • 52 Week High: 71.80
  • 52 Week Low: 34.05
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 220,943
  • Market Cap: £189.14m
  • RiskGrade: 119

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.
Registrars: Capita Registrars

Key Personnel

CEO: Peter Butterfield
CFO: Andrew Franklin
Chairman: Camillo Pane
Chief Operating Officer: Jeyan Heper
Independent Non-Executive Director: Martin Sutherland
Independent Non-Executive Director: Kristof Neirynck
Senior Independent Director: Richard Jones
Non-Executive Dir: Richard McKenzie , Eva-Lotta Sjöstedt

Contact Details

Address: Avonbridge House, Bath Road, Chippenham, Wiltshire, United Kingdom, SN15 2BB
Phone: +44 (0)1249 466966
Fax: +44 (0)1249 466977
Website: http://www.alliancepharma.co.uk

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB0031030819

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 35.00p
Change Today 0.100p
% Change 0.29 %
52 Week High 71.80
52 Week Low 34.05
Volume 220,943
Shares Issued 540.40m
Market Cap £189.14m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.31% above the market average84.31% above the market average84.31% above the market average84.31% above the market average84.31% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
68.22% below the market average68.22% below the market average68.22% below the market average68.22% below the market average68.22% below the market average
1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average
Income
9.89% above the market average9.89% above the market average9.89% above the market average9.89% above the market average9.89% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
88.8% below the market average88.8% below the market average88.8% below the market average88.8% below the market average88.8% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 26-Apr-2024

Time Volume / Share Price
16:29 6 @ 35.00p
16:29 6 @ 35.00p
16:29 7 @ 35.00p
16:29 19 @ 35.00p
16:28 94 @ 34.98p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page